ATHE
Price
$3.45
Change
-$0.08 (-2.27%)
Updated
Oct 2, 04:51 PM (EDT)
Capitalization
61.26M
Intraday BUY SELL Signals
TECX
Price
$22.50
Change
-$0.17 (-0.75%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
459.61M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATHE vs TECX

ATHE vs TECX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ATHE vs. TECX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Hold and TECX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ATHE vs TECX: Fundamental Ratings
ATHE
TECX
OUTLOOK RATING
1..100
651
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
10056
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (52) in the null industry is in the same range as ATHE (79) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

TECX's SMR Rating (97) in the null industry is in the same range as ATHE (98) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

TECX's Price Growth Rating (64) in the null industry is in the same range as ATHE (64) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

TECX's P/E Growth Rating (56) in the null industry is somewhat better than the same rating for ATHE (100) in the Biotechnology industry. This means that TECX’s stock grew somewhat faster than ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHETECX
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ATHE: $3.53 vs. TECX: $22.67)
Brand notoriety: ATHE and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 220% vs. TECX: 177%
Market capitalization -- ATHE: $61.26M vs. TECX: $459.61M
ATHE [@Biotechnology] is valued at $61.26M. TECX’s [@Biotechnology] market capitalization is $459.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green while TECX’s FA Score has 0 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 0 green, 5 red.
According to our system of comparison, TECX is a better buy in the long-term than ATHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 4 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • ATHE’s TA Score: 4 bullish, 4 bearish.
  • TECX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATHE is a better buy in the short-term than TECX.

Price Growth

ATHE (@Biotechnology) experienced а -4.08% price change this week, while TECX (@Biotechnology) price change was -6.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

TECX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ATHE
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSUI23.810.89
+3.89%
21Shares Sui Staking ETF Common Shares of Beneficial Interest Shares (TSUI)
CLOD35.670.41
+1.18%
Themes Cloud Computing ETF (CLOD)
PDP138.991.16
+0.84%
Invesco Dorsey Wright Momentum ETF (PDP)
TMFG29.85-0.12
-0.40%
Motley Fool Global Opportunities ETF (TMFG)
IBBQ34.42-0.72
-2.05%
Invesco Nasdaq Biotechnology ETF (IBBQ)

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
-2.49%
EYPT - ATHE
54%
Loosely correlated
-1.22%
SLDB - ATHE
38%
Loosely correlated
-3.46%
TECX - ATHE
35%
Loosely correlated
-2.66%
GHRS - ATHE
31%
Poorly correlated
-2.64%
IVVD - ATHE
30%
Poorly correlated
-6.16%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with ENVB. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then ENVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
-2.66%
ENVB - TECX
61%
Loosely correlated
-0.68%
IGC - TECX
49%
Loosely correlated
+0.41%
DNTH - TECX
39%
Loosely correlated
+0.31%
KURA - TECX
39%
Loosely correlated
-0.56%
BCTX - TECX
38%
Loosely correlated
-3.97%
More